Cargando…

Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers

Solid serous cystadenoma (SCA) of the pancreas is a rare type of pancreatic solid tumors. Postoperative pathological evaluation is of particular importance for distinguishing solid SCA of the pancreas from other pancreatic solid tumors. Here we present 2 cases of solid SCA of the pancreas, both preo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wenming, Hong, Xiafei, Li, Ji, Dai, Menghua, Wang, Wenze, Tong, Anli, Zhu, Zhaohui, Dai, Hongmei, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554012/
https://www.ncbi.nlm.nih.gov/pubmed/25816032
http://dx.doi.org/10.1097/MD.0000000000000644
_version_ 1782387992432738304
author Wu, Wenming
Hong, Xiafei
Li, Ji
Dai, Menghua
Wang, Wenze
Tong, Anli
Zhu, Zhaohui
Dai, Hongmei
Zhao, Yupei
author_facet Wu, Wenming
Hong, Xiafei
Li, Ji
Dai, Menghua
Wang, Wenze
Tong, Anli
Zhu, Zhaohui
Dai, Hongmei
Zhao, Yupei
author_sort Wu, Wenming
collection PubMed
description Solid serous cystadenoma (SCA) of the pancreas is a rare type of pancreatic solid tumors. Postoperative pathological evaluation is of particular importance for distinguishing solid SCA of the pancreas from other pancreatic solid tumors. Here we present 2 cases of solid SCA of the pancreas, both preoperatively diagnosed with pancreatic neuroendocrine tumors. One case had positive OctreoScan test. Surgical resections were done for both cases. Postoperative immunohistochemistry assays were conducted with marker panels for SCA and 2 types of pancreatic solid tumors, which were neuroendocrine tumor (pNET) and solid pseudopapillary tumor (SPT). Two cases showed typical staining patterns for SCA markers. Notably, both cases showed positivity for 4 SPT markers (vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin). Emphasis should be paid to those 4 new markers for future pathological diagnosis of solid SCA of the pancreas.
format Online
Article
Text
id pubmed-4554012
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-45540122015-10-27 Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers Wu, Wenming Hong, Xiafei Li, Ji Dai, Menghua Wang, Wenze Tong, Anli Zhu, Zhaohui Dai, Hongmei Zhao, Yupei Medicine (Baltimore) 5700 Solid serous cystadenoma (SCA) of the pancreas is a rare type of pancreatic solid tumors. Postoperative pathological evaluation is of particular importance for distinguishing solid SCA of the pancreas from other pancreatic solid tumors. Here we present 2 cases of solid SCA of the pancreas, both preoperatively diagnosed with pancreatic neuroendocrine tumors. One case had positive OctreoScan test. Surgical resections were done for both cases. Postoperative immunohistochemistry assays were conducted with marker panels for SCA and 2 types of pancreatic solid tumors, which were neuroendocrine tumor (pNET) and solid pseudopapillary tumor (SPT). Two cases showed typical staining patterns for SCA markers. Notably, both cases showed positivity for 4 SPT markers (vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin). Emphasis should be paid to those 4 new markers for future pathological diagnosis of solid SCA of the pancreas. Wolters Kluwer Health 2015-03-27 /pmc/articles/PMC4554012/ /pubmed/25816032 http://dx.doi.org/10.1097/MD.0000000000000644 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial License, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 5700
Wu, Wenming
Hong, Xiafei
Li, Ji
Dai, Menghua
Wang, Wenze
Tong, Anli
Zhu, Zhaohui
Dai, Hongmei
Zhao, Yupei
Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
title Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
title_full Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
title_fullStr Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
title_full_unstemmed Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
title_short Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
title_sort solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markers
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554012/
https://www.ncbi.nlm.nih.gov/pubmed/25816032
http://dx.doi.org/10.1097/MD.0000000000000644
work_keys_str_mv AT wuwenming solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT hongxiafei solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT liji solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT daimenghua solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT wangwenze solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT tonganli solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT zhuzhaohui solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT daihongmei solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers
AT zhaoyupei solidserouscystadenomaofthepancreasacasereportof2patientsrevealingvimentinbcatenina1antitrypsinanda1antichymotrypsinasnewimmunohistochemistrystainingmarkers